O

OPKO Health
D

OPK

1.58000
USD
-0.08
(-4.53%)
Market Closed
Volume
70,087
EPS
-0
Div Yield
-
P/E
-20
Market Cap
1,252,921,463
Related Instruments
A
AUPH
-0.16000
(-1.95%)
8.04000 USD
E
EXEL
-0.385
(-1.04%)
36.685 USD
I
IBIO
-0.30500
(-7.43%)
3.80000 USD
LLY
LLY
-28.72
(-3.51%)
788.94 USD
MRK
MRK
-0.220
(-0.25%)
86.370 USD
NFLX
NFLX
-18.76
(-2.01%)
916.79 USD
N
NVAX
-0.38500
(-6.44%)
5.59500 USD
PFE
PFE
-0.385
(-1.56%)
24.290 USD
More
News

Title: OPKO Health

Sector: Healthcare
Industry: Diagnostics & Research
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.